BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  New Clinical Data for Vivace Therapeutics’ Best-in-Class, Hippo Pathway-Targeting Therapy to be Presented in Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2025

  October 9, 2025

   · 

  2 min read
• Press Releases

  Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025

  October 9, 2025

   · 

  14 min read
• Press Releases

  Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Embolden™ Registrational Trial in Q4 2025

  October 9, 2025

   · 

  9 min read
• Press Releases

  ESSA Announces Completion of Arrangement with XenoTherapeutics

  October 9, 2025

   · 

  7 min read
• Press Releases

  Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma

  October 9, 2025

   · 

  3 min read
• Press Releases

  Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for High Efficiency Gene Insertion in Dividing and Non-Dividing Cells Using ARCUS Nucleases

  October 9, 2025

   · 

  9 min read
• Press Releases

  BioSpring Enters Strategic Partnership with Luxna Biotech to Offer Manufacture of Oligonucleotides with Luxna´s advanced XNA Amidites

  October 9, 2025

   · 

  1 min read
• Press Releases

  U.S. Generic Drugs Market Size to Reach USD 196.90 Billion By 2034

  October 9, 2025

   · 

  1 min read
• Press Releases

  American Society of Hematology Accepts Telo Genomics’ Abstract for Presentation at its 2025 Meeting and Exposition

  Recognition highlights commercial potential of Telo’s telomere-based MRD technology in the growing precision oncology market

  October 9, 2025

   · 

  6 min read
• Press Releases

  OS Therapies Provides Positive EMA Regulatory Update Following Positive Rapporteur Meeting

  Overall survival recognized as key efficacy endpoint in osteosarcoma, where no standard of care exists Rapporteur highlights potential broader benefits of OST-HER2 in pulmonary and primary osteosarcoma settings, supported by translational canine data from the University of Pennsylvania

  October 9, 2025

   · 

  6 min read